PortfoliosLab logo
UTMD vs. SPY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between UTMD and SPY is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

UTMD vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Utah Medical Products, Inc. (UTMD) and SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

UTMD:

-0.87

SPY:

0.70

Sortino Ratio

UTMD:

-1.42

SPY:

1.02

Omega Ratio

UTMD:

0.83

SPY:

1.15

Calmar Ratio

UTMD:

-0.33

SPY:

0.68

Martin Ratio

UTMD:

-1.09

SPY:

2.57

Ulcer Index

UTMD:

16.89%

SPY:

4.93%

Daily Std Dev

UTMD:

18.83%

SPY:

20.42%

Max Drawdown

UTMD:

-55.58%

SPY:

-55.19%

Current Drawdown

UTMD:

-52.72%

SPY:

-3.55%

Returns By Period

In the year-to-date period, UTMD achieves a -9.91% return, which is significantly lower than SPY's 0.87% return. Over the past 10 years, UTMD has underperformed SPY with an annualized return of 1.74%, while SPY has yielded a comparatively higher 12.73% annualized return.


UTMD

YTD

-9.91%

1M

5.52%

6M

-14.72%

1Y

-17.79%

3Y*

-12.50%

5Y*

-9.59%

10Y*

1.74%

SPY

YTD

0.87%

1M

5.54%

6M

-1.56%

1Y

13.18%

3Y*

14.25%

5Y*

15.81%

10Y*

12.73%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Utah Medical Products, Inc.

SPDR S&P 500 ETF

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

UTMD vs. SPY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UTMD
The Risk-Adjusted Performance Rank of UTMD is 1515
Overall Rank
The Sharpe Ratio Rank of UTMD is 77
Sharpe Ratio Rank
The Sortino Ratio Rank of UTMD is 66
Sortino Ratio Rank
The Omega Ratio Rank of UTMD is 88
Omega Ratio Rank
The Calmar Ratio Rank of UTMD is 2929
Calmar Ratio Rank
The Martin Ratio Rank of UTMD is 2323
Martin Ratio Rank

SPY
The Risk-Adjusted Performance Rank of SPY is 6262
Overall Rank
The Sharpe Ratio Rank of SPY is 6060
Sharpe Ratio Rank
The Sortino Ratio Rank of SPY is 5959
Sortino Ratio Rank
The Omega Ratio Rank of SPY is 6262
Omega Ratio Rank
The Calmar Ratio Rank of SPY is 6565
Calmar Ratio Rank
The Martin Ratio Rank of SPY is 6363
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

UTMD vs. SPY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Utah Medical Products, Inc. (UTMD) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current UTMD Sharpe Ratio is -0.87, which is lower than the SPY Sharpe Ratio of 0.70. The chart below compares the historical Sharpe Ratios of UTMD and SPY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

UTMD vs. SPY - Dividend Comparison

UTMD's dividend yield for the trailing twelve months is around 2.20%, more than SPY's 1.22% yield.


TTM20242023202220212020201920182017201620152014
UTMD
Utah Medical Products, Inc.
2.20%1.96%1.41%1.16%2.86%1.33%1.02%1.31%1.31%1.44%1.75%1.67%
SPY
SPDR S&P 500 ETF
1.22%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%1.87%

Drawdowns

UTMD vs. SPY - Drawdown Comparison

The maximum UTMD drawdown since its inception was -55.58%, roughly equal to the maximum SPY drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for UTMD and SPY.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

UTMD vs. SPY - Volatility Comparison

Utah Medical Products, Inc. (UTMD) and SPDR S&P 500 ETF (SPY) have volatilities of 4.67% and 4.86%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...